LGT Fund Management invests $308k in Boston Scientific Co., whose Q2 earnings surpass estimates.
LGT Fund Management recently invested $308,000 in Boston Scientific Co. (NYSE: BSX), adding to the significant institutional ownership of 89.07% in the company. Boston Scientific reported Q2 earnings of $0.62 per share, surpassing estimates, with revenues of $4.12 billion, a 14.5% year-over-year increase. Analysts have boosted price targets, reflecting a consensus "Moderate Buy" rating with a target of $85.38.
September 11, 2024
7 Articles